Sildenafil Citrate (India)
Producing a generic drug in India may be done at reduced costs. That is the main reason of the low cost of Sildenafil. It can still earn a profit when sold at a fraction of the cost of a brand name medication.
The following expenses that the brand name pharmaceutical companies mast bear, may be avoided by the manufactures of Sildenafil India:
(1) Cost of research and development that are very expensive.
(2) Expense of acquiring a formal agreement is lower in India.
(3) Reduced marketing costs for generics such as Sildenafil India.
First of all, generic manufacturers do not hold up research and development expenses. They produce generics which are equivalents of brand-name drugs such as Viagra®.
Secondly, generic manufacturers do not do clinical research studies. The brand-name drug effectiveness is reproduced in the generic tablets. Sildenafil India is the generic version of the existing brand-name product that has proved to have a favorable outcome over the years.
Third, these companies receive the added advantage of the marketing and advertising that goes into promoting the original brand name drug. Viagra has shown to be successful. That matter stimulates the sale of the generic version, Sildenafil India, and the manufacturers do not need to spend a lot of money on promotion. The brand name medication has been present on the market for around a decade. The Indian manufacturers do not have to give away samples to physicians as drug companies in the US do.
Large pharmaceutical companies have to bear the notable research, development and marketing costs in presenting a new drug to the market. Brand-name drug manufactures are often blamed for the high price of brand name medicines. The original manufacturers must get back their expenditures before the patent on the drug expires. Generic manufacturers from India do not have to spend these costs, with bioequivalence testing and manufacturing costing relatively little. This allows them to sell the generics at lower prices, including Sildenafil India.